107 results match your criteria: "Paris Sciences Lettres Research University[Affiliation]"
Biomolecules
September 2024
Cellular and Chemical Biology Unit, Institut Curie, Paris Sciences & Lettres Research University, U1143 INSERM, UMR3666 CNRS, 75248 Paris, France.
Essentially all plasma membrane proteins are glycosylated, and their activity is regulated by tuning their cell surface dynamics. This is achieved by glycan-binding proteins of the galectin family that either retain glycoproteins within lattices or drive their endocytic uptake via the clathrin-independent glycolipid-lectin (GL-Lect) mechanism. Here, we have used immunofluorescence-based assays to analyze how lattice and GL-Lect mechanisms affect the internalization of the cell adhesion and migration glycoprotein αβ integrin.
View Article and Find Full Text PDFCancer Med
August 2024
Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Background: BRCA1:c.5017_5019del (p.His1673del) is a founder variant relatively frequent in Northern Italy.
View Article and Find Full Text PDFAm J Hum Genet
September 2024
Population Health, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia. Electronic address:
Eur J Hum Genet
November 2024
UF of Psychology and Liaison and Emergency Psychiatry, DMU Psychiatry and Addictology, Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.
In paediatric oncology, genomics raises new ethical, legal and psychological issues, as somatic and constitutional situations intersect throughout the care pathway. The discovery of potential predisposition in this context is sometimes carried out outside the usual framework. This article focuses on the views of children, adolescents, and young adults (AYA) with cancer and their parents about their experience with genomic testing.
View Article and Find Full Text PDFNeurooncol Adv
May 2024
Université Paris Cité, SIREDO Pediatric Cancer Center, Institut Curie, Paris, France.
Background: pathogenic variants (PV) have been recently identified as the most frequent variants predisposing to Sonic Hedgehog (SHH) medulloblastomas (MB); however, guidelines are still lacking for genetic counseling in this new syndrome.
Methods: We retrospectively reviewed clinical and genetic data of a French series of 29 -mutated MB.
Results: All patients developed SHH-MB, with a biallelic inactivation of found in 24 tumors.
Proc Natl Acad Sci U S A
April 2024
Department of Applied Physics, Aalto University, Espoo 02150, Finland.
Superhydrophobic surfaces are often seen as frictionless materials, on which water is highly mobile. Understanding the nature of friction for such water-repellent systems is central to further minimize resistance to motion and energy loss in applications. For slowly moving drops, contact-line friction has been generally considered dominant on slippery superhydrophobic surfaces.
View Article and Find Full Text PDFCancers (Basel)
April 2024
Department of Radiation Oncology, Institut Curie, 75248 Paris, France.
The Ataxia-Telangiectasia Mutated gene is implicated in DNA double-strand break repair. Controversies in clinical radiosensitivity remain known for monoallelic carriers of the pathogenic variant (PV). An evaluation of the single-nucleotide polymorphism (SNP) rs1801516 (G-A) showed different results regarding late subcutaneous fibrosis after breast radiation therapy (RT).
View Article and Find Full Text PDFNat Commun
April 2024
Université Paris Cité, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Institut Cochin, Paris, France.
Myelodysplastic syndromes (MDS) with mutated SF3B1 gene present features including a favourable outcome distinct from MDS with mutations in other splicing factor genes SRSF2 or U2AF1. Molecular bases of these divergences are poorly understood. Here we find that SF3B1-mutated MDS show reduced R-loop formation predominating in gene bodies associated with intron retention reduction, not found in U2AF1- or SRSF2-mutated MDS.
View Article and Find Full Text PDFBrain Pathol
November 2024
Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France.
Meningioangiomatosis (MAM) remains a poorly understood lesion responsible for epileptic disease. In the past, MAM was primarily described in the context of neurofibromatosis type 2 before being mainly reported sporadically. Moreover, the malformative or tumoral nature is still debated.
View Article and Find Full Text PDFUsing field observations from a sanctuary, Oña and colleagues (DOI: 10.7717/peerj.7623) investigated the semantics of face-gesture combinations in chimpanzees ().
View Article and Find Full Text PDFJ Neuropathol Exp Neurol
January 2024
Department of Neuropathology, GHU Paris-Psychiatry and Neurosciences, Sainte-Anne Hospital, Paris, France.
Neuropathol Appl Neurobiol
February 2024
Department of Neurology 2-Mazarin, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau Et de La Moelle Épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Paris, France.
Breast
February 2024
Department of genetics, Curie Institute, Paris, France; Université Paris Cité, Paris, France.
Breast cancers (BC) are rare in men and are often caused by constitutional predisposing factors. In women, mosaic BRCA1 promoter methylations (MBPM) are frequent events, detected in 4-8% of healthy subjects. This constitutional epimutation increases risk of early-onset and triple-negative BC.
View Article and Find Full Text PDFJ Natl Cancer Inst
April 2024
Department of Genetics, Institut Curie, Paris, France.
Background: Monoallelic germline MBD4 pathogenic variants were recently reported to cause a predisposition to uveal melanoma, associated with a specific tumor mutational signature and good response to immunotherapy. Monoallelic tumor pathogenic variants have also been described in brain tumors, breast cancers, and myxofibrosarcomas, whereas biallelic germline MBD4 pathogenic variants have been involved in a recessive hereditary adenomatous polyposis and a specific type of acute myeloid leukemia.
Methods: We analyzed MBD4 for all patients with a diagnosis of uveal melanoma at Institut Curie since July 2021 and in the 3240 consecutive female probands explored at the Institut Curie for suspicion of predisposition to breast cancer between July 2021 and February 2023.
Oncogene
November 2023
Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) Team, Institut Curie and Paris Sciences Lettres Research University, Paris, France.
The bevacizumab (bev)/olaparib (ola) maintenance regimen was approved for BRCA1/2-mutated (BRCAmut) and Homologous Recombination Deficient (HRD) high-grade Advanced Ovarian Cancer (AOC) first line setting, based on a significantly improved progression-free survival (PFS) compared to bev alone in the PAOLA-1/ENGOT-ov25 trial (NCT02477644), where HRD was detected by MyChoice CDx PLUS test. The academic shallowHRDv2 test was developed based on shallow whole-genome sequencing as an alternative to MyChoice. Analytical and clinical validities of shallowHRDv2 as compared to MyChoice on 449 PAOLA-1 tumor samples are presented.
View Article and Find Full Text PDFJ Med Genet
February 2024
Department of genetics, Curie Institute Hospital Group, Paris, France.
Purpose: Mosaic promoter methylation (meth) increases the risk of early-onset breast cancer, triple-negative breast cancer and ovarian cancer. As mosaic meth are believed to occur de novo, their role in family breast/ovarian cancer has not been assessed.
Patients: Blood-derived DNA from 20 unrelated affected cases from families with aggregation of breast/ovarian cancer, but with no germline pathogenic variants in /, or , were screened by methylation-sensitive high-resolution melting.
Acta Neuropathol Commun
August 2023
Research In Pediatric, Adolescent and Young Adult Oncology, Laboratory of Translationnal Research in Pediatric Oncology, Institut Curie Institute, SIREDO Center Care, INSERM U830, Paris Sciences Lettres Research University, Innovation, Paris, France.
Neuropathol Appl Neurobiol
August 2023
Department of Genetics, Institut Curie, Paris, France.
Brain Pathol
September 2023
Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France.
Cancer Gene Ther
August 2023
Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.
The tumor suppressor gene WWOX is localized in an unstable chromosomal region and its expression is decreased or absent in several types of cancer. A low expression of WWOX is associated with a poor prognosis in breast cancer (BC). It has recently been shown that WWOX contributes to genome stability through its role in the DNA damage response (DDR).
View Article and Find Full Text PDFBiol Rev Camb Philos Soc
October 2023
CNRS UMR8590, Institut d'Histoire et Philosophie des Sciences et des Technique, University Paris I Panthéon-Sorbonne, 13 rue du Four, Paris, 75006, France.
Cancers rely on multiple, heterogeneous processes at different scales, pertaining to many biomedical fields. Therefore, understanding cancer is necessarily an interdisciplinary task that requires placing specialised experimental and clinical research into a broader conceptual, theoretical, and methodological framework. Without such a framework, oncology will collect piecemeal results, with scant dialogue between the different scientific communities studying cancer.
View Article and Find Full Text PDFClin Genet
July 2023
Department of Genetics, Institut Curie, Paris, France.
In breast or ovarian cancer (BC/OC) patients with evocative personal and/or family history, multigene panel sequencing is performed on blood to diagnose hereditary predispositions. Additionally, BRCA1/BRCA2 testing can be performed on tumor sample for therapeutic purpose. The accuracy of multigene panel tumor analysis on BC/OC to detect predisposing germline pathogenic variants (gPV) has not been precisely assessed.
View Article and Find Full Text PDFHum Mutat
May 2024
Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Genes Chromosomes Cancer
April 2023
Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.
Only a few patients with germline AXIN2 variants and colorectal adenomatous polyposis or cancer have been described, raising questions about the actual contribution of this gene to colorectal cancer (CRC) susceptibility. To assess the clinical relevance for AXIN2 testing in patients suspected of genetic predisposition to CRC, we collected clinical and molecular data from the French Oncogenetics laboratories analyzing AXIN2 in this context. Between 2004 and June 2020, 10 different pathogenic/likely pathogenic AXIN2 variants were identified in 11 unrelated individuals.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
November 2022
Center for Interdisciplinary Research in Biology, CNRS UMR 7241, INSERM U1050, Collège de France and Paris Sciences & Lettres Research University, 75231 Paris Cedex 05, France.
In the early stages of meiosis, maternal and paternal chromosomes pair with their homologous partner and recombine to ensure exchange of genetic information and proper segregation. These events can vary drastically between species and between males and females of the same species. In in contrast to females, males do not form synaptonemal complexes (SCs), do not recombine, and have no crossing over; yet, males are able to segregate their chromosomes properly.
View Article and Find Full Text PDF